MTNB · Matinas BioPharma Holdings, Inc.
What's happening
- MTNB is down 8.93% today, trading at $1.53. — Live quote
- It's trading within 3% of its 52-week low ($1.50). (Finnhub fundamentals)
- Volume today (475) is well below its 3-month average of 296,830. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.82 actual vs. $-0.91 estimated (+9.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2025-10-01 (7 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $61.7M | $48.0M | $110.9M | $71.0M | $40.7M |
| P/E | -6.16 | -4.64 | -8.73 | -4.20 | -2.33 |
| Price/Book | 34.28 | 15.89 | 17.16 | 9.26 | 6.48 |
| EV/EBITDA | — | — | -10.96 | — | — |
| ROE | -556.89% | -342.62% | -196.72% | -220.13% | -278.69% |
| ROA | -293.79% | -176.27% | -131.08% | -147.89% | -145.19% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-09-28; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -479.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -93.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on MTNB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$1.6M | -$1.9M | -$1.6M | -$1.8M | -$1.9M | -$4.4M | -$5.8M | -$5.9M |
| Net income | -$1.3M | -$1.9M | -$1.5M | -$5.2M | -$1.7M | -$4.3M | -$5.7M | -$5.8M |
| EPS (diluted) | $-0.21 | $-0.30 | $-0.40 | $-1.03 | $-0.33 | $-0.85 | $-1.15 | $-1.34 |
| EPS (basic) | $-0.21 | $-0.30 | $-0.40 | $-1.03 | $-0.33 | $-0.85 | $-1.15 | $-1.34 |
Balance sheet
| Line item | Dec '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | — | $3.4M | $5.9M | $7.2M | $9.7M | $11.4M | $12.0M | $12.6M |
| Total liabilities | — | $1.6M | $2.9M | $2.4M | $3.2M | $3.7M | $5.8M | $5.1M |
| Stockholders' equity | — | $1.8M | $3.0M | $4.8M | $6.5M | $7.7M | $6.3M | $7.6M |
| Total current assets | — | $1.1M | $2.8M | $4.1M | $5.7M | $7.3M | $7.5M | $8.0M |
| Total current liabilities | — | $1.4M | $2.1M | $1.5M | $1.5M | $1.8M | $2.3M | $2.7M |
| Cash & equivalents | — | $761.0K | $2.4M | $4.0M | $5.4M | $6.5M | $6.9M | $7.3M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $138.0K | — | $138.0K | $138.0K | $156.0K | $158.0K | $450.0K | $468.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible assets | — | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M |
| Accounts payable | — | $845.0K | $712.0K | $315.0K | $80.0K | $167.0K | $282.0K | $95.0K |
| Accrued liabilities | — | $504.0K | $694.0K | $452.0K | $564.0K | $795.0K | $1.2M | $1.8M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | — | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained earnings | — | -$214.0M | -$212.7M | -$210.8M | -$208.9M | -$206.7M | -$201.5M | -$199.8M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.8M | -$1.6M | -$1.5M | -$1.5M | -$2.0M | -$2.0M | -$3.5M | -$3.5M |
| Investing cash flow | — | — | $15.0K | $320.0K | — | — | $500.0K | $9.6M |
| Financing cash flow | -$1.0K | — | $58.0K | $64.0K | $1.6M | $1.6M | -$1.0K | -$67.0K |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | — | — | $3.0K | -$1.0K | $12.0K | $18.0K | $90.0K | $91.0K |
| Share-based compensation | $104.0K | $113.0K | $708.0K | $253.0K | $238.0K | $315.0K | $2.2M | $965.0K |
| Deferred income taxes | — | — | — | — | — | — | -$84.0K | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in accounts payable | $132.0K | $397.0K | $235.0K | -$86.0K | -$116.0K | $187.0K | -$254.0K | $111.0K |
| Purchases of investments | — | — | — | — | — | — | $0 | $499.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | $1.1M | $3.2M | $33.0K |
| Operating income | -$7.0M | -$24.6M | -$23.8M | -$24.6M | -$24.7M |
| Net income | -$10.3M | -$24.3M | -$22.9M | -$21.0M | -$23.3M |
| EPS (diluted) | $-2.00 | $-4.98 | $-5.28 | $-0.10 | — |
| EPS (basic) | $-2.00 | $-4.98 | $-5.28 | $-0.10 | $-0.11 |
| Operating margin | — | — | -$2.2K | -$771 | -$75.0K |
| Net margin | — | — | -$2.1K | -$659 | -$70.6K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $7.2M | $12.6M | $25.1M | $44.8M | $61.3M |
| Total liabilities | $2.4M | $5.1M | $5.9M | $8.2M | $8.8M |
| Stockholders' equity | $4.8M | $7.6M | $19.2M | $36.6M | $52.5M |
| Total current assets | $4.1M | $8.0M | $15.5M | $34.5M | $51.0M |
| Total current liabilities | $1.5M | $2.7M | $2.6M | $4.3M | $4.3M |
| Cash & equivalents | $4.0M | $7.3M | $4.8M | $6.8M | $21.0M |
| Marketable securities (current) | — | — | $9.0M | $21.9M | $28.6M |
| Property, plant & equipment | $138.0K | $468.0K | $1.9M | $2.1M | $1.5M |
| Goodwill | — | — | $1.3M | $1.3M | $1.3M |
| Intangible assets | $2.3M | $2.3M | $3.0M | $3.0M | $3.0M |
| Accounts payable | $315.0K | $95.0K | $514.0K | $618.0K | $937.0K |
| Accrued liabilities | $452.0K | $1.8M | $1.4M | $3.1M | $2.9M |
| Common stock & paid-in capital | $1.0K | $1.0K | $22.0K | $22.0K | $22.0K |
| Retained earnings | -$210.8M | -$199.8M | -$175.6M | -$152.6M | -$131.6M |
| Accumulated other comprehensive income (loss) | — | — | -$221.0K | -$824.0K | -$145.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$7.0M | -$15.9M | -$15.3M | -$19.2M | -$15.2M |
| Investing cash flow | $335.0K | $9.2M | $13.2M | $4.9M | $16.8M |
| Financing cash flow | $3.4M | $9.2M | -$7.0K | $79.0K | $7.0M |
| Free cash flow | — | — | -$15.5M | -$20.0M | -$15.5M |
| Capital expenditures | — | — | $218.0K | $892.0K | $260.0K |
| Depreciation & amortization | $32.0K | $365.0K | $385.0K | $337.0K | $244.0K |
| Share-based compensation | $1.0M | $3.2M | $4.9M | $5.2M | $4.3M |
| Deferred income taxes | — | -$84.0K | — | — | — |
| Change in accounts payable | $220.0K | -$419.0K | -$103.0K | -$321.0K | $588.0K |
| Purchases of investments | — | $8.4M | — | $9.5M | $23.2M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding MTNB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-10-31 to 2026-07-10
Recent transactions
- Most recent: STERN ADAM K (10% owner) — In-the-money option exercise of 344,710 shares on 2026-07-10.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| STERN ADAM K | 10% owner | In-the-money option exercise | 2026-07-10 | 344,710 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-10 | STERN ADAM K | 10% owner | In-the-money option exercise | 344,710 | $0.35 |
| 2026-07-10 | STERN ADAM K | 10% owner | In-the-money option exercise | 630,335 | $0.35 |
| 2025-10-31 | STERN ADAM K | 10% owner | In-the-money option exercise | 92,100 | $0.64 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:48 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-28 | 8-K | 2026-09-25 | View on SEC.gov → |
| 2026-09-16 | 8-K | 2026-09-16 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-08-31 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 4 | 2025-10-16 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-07-24 | 8-K | 2026-07-23 | View on SEC.gov → |
| 2026-07-13 | 8-K | 2026-07-10 | View on SEC.gov → |
| 2026-06-26 | 8-K | 2026-06-24 | View on SEC.gov → |
| 2026-05-08 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-03 | 8-K | 2026-04-02 | View on SEC.gov → |
| 2026-03-31 | 10-K | 2025-12-31 | View on SEC.gov → |
Recent news
Headlines about MTNB (Matinas BioPharma Holdings, Inc.). Links open the publisher — we don’t host full articles.
-
GH Power Signs Multi-Year Hydrogen Offtake Agreement with Change Energy for Hamilton Facility Output
Yahoo Finance · 2026-09-14 -
Matinas BioPharma gets 2027 window to restore NYSE American listing compliance
Seeking Alpha · 2026-09-04 -
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Yahoo Finance · 2026-09-04 -
GH Power and TKMS Continue to Explore Clean Energy Collaboration in Support of Canada’s Future Patrol Submarine Project
Yahoo Finance · 2026-07-30 -
GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Public through Business Combination with Matinas BioPharma
Yahoo Finance · 2026-07-13 -
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals
Yahoo Finance · 2026-07-13 -
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
Yahoo Finance · 2026-06-26 -
Matinas BioPharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call Transcript
Seeking Alpha · 2024-08-14
No headlines in this category right now — try “All”.